Tear Markers After Laser Glaucoma Treatment
Part of Eyes & vision clinical trials.
This study looks at tiny proteins in your tears after a specific laser treatment for glaucoma (a disease that damages the nerve in your eye). Researchers want to understand how these tear markers change and whether they might help predict how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have glaucoma that isn't controlled well enough with eye drops alone
- You are 18 years old or older
- Your doctor has decided you are ready for MP-CPC laser treatment
- Your eye tissue (sclera) is not unusually thin
- You have not had eye infection, inflammation, or eye surgery in the past 2 months
- You are able and willing to attend follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares levels of inflammatory markers (cytokines) in the fluid inside your eye and your tears before and after a procedure called UCP (ultrasound cycloplasty) to treat glaucoma. It aims to understand how the eye responds, which may lead to better treatments for high eye pressure.
This trial tests how well a laser treatment called selective laser trabeculoplasty works in people with open-angle glaucoma. It looks at results over 12 months to see if it helps lower eye pressure.
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
This trial looks at whether a specific eye laser treatment done through the white of the eye (called transscleral cyclophotocoagulation) works well and is safe for people getting a Boston keratoprosthesis. It may help improve comfort and vision outcomes for selected patients needing this type of cornea/eye replacement surgery.
This study tests whether a laser treatment helps keep eye pressure stable in people with early glaucoma or high eye pressure who have not used any eye drops or medications before. It may be a good option if you are looking for a treatment that doesn't require daily eye drops.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.